These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19742144)

  • 21. Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.
    Nishikawa Y; Hoshino N; Horimatsu T; Funakoshi T; Hida K; Sakai Y; Muto M; Nakayama T
    Int J Clin Oncol; 2020 Aug; 25(8):1441-1449. PubMed ID: 32448950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capecitabine cardiotoxicity--case reports and literature review.
    Manojlovic N; Babic D; Stojanovic S; Filipovic I; Radoje D
    Hepatogastroenterology; 2008; 55(85):1249-56. PubMed ID: 18795667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
    Pai VB; Nahata MC
    Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indole Alkaloid Derivative B, a Novel Bifunctional Agent That Mitigates 5-Fluorouracil-Induced Cardiotoxicity.
    Bi W; Bi Y; Li P; Hou S; Yan X; Hensley C; Bammert CE; Zhang Y; Gibson KM; Ju J; Bi L
    ACS Omega; 2018 Nov; 3(11):15850-15864. PubMed ID: 30533582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The spectrum of 5-fluorouracil cardiotoxicity.
    Dalzell JR; Samuel LM
    Anticancer Drugs; 2009 Jan; 20(1):79-80. PubMed ID: 19353811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiotoxicity during chemotherapy treatment with 5-fluorouracil and cisplatin.
    Jeremic B; Jevremovic S; Djuric L; Mijatovic L
    J Chemother; 1990 Aug; 2(4):264-7. PubMed ID: 2230913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiotoxicity of the antiproliferative compound fluorouracil.
    Becker K; Erckenbrecht JF; Häussinger D; Frieling T
    Drugs; 1999 Apr; 57(4):475-84. PubMed ID: 10235688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-fluorouracil-induced cardiotoxicity mimicking myocardial infarction: a case report.
    McGlinchey PG; Webb ST; Campbell NP
    BMC Cardiovasc Disord; 2001; 1():3. PubMed ID: 11734065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy for primary adenocarcinoma of the small bowel.
    Jigyasu D; Bedikian AY; Stroehlein JR
    Cancer; 1984 Jan; 53(1):23-5. PubMed ID: 6690001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resection of small bowel adenocarcinoma liver metastasis combined with neoadjuvant and adjuvant chemotherapy results in extended disease-free period--a case report.
    Eigenbrod T; Kullmann F; Klebl F
    Int J Gastrointest Cancer; 2006; 37(2-3):94-7. PubMed ID: 17827529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxaliplatin/5-fluorouracil/leucovorin (FOLFOX4) regimen as an adjuvant chemotherapy in the treatment of advanced jejunal adenocarcinoma: a report of 2 cases.
    Chen CW; Wang WM; Su YC; Wu JY; Hsieh JS; Wang JY
    Med Princ Pract; 2008; 17(6):496-9. PubMed ID: 18836281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
    Maurer U; Härle M; Jungius KP
    Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucinous adenocarcinoma of the small bowel with peritoneal seeding.
    Marchettini P; Sugarbaker PH
    Eur J Surg Oncol; 2002 Feb; 28(1):19-23. PubMed ID: 11869008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report.
    Kuropkat C; Griem K; Clark J; Rodriguez ER; Hutchinson J; Taylor SG
    Am J Clin Oncol; 1999 Oct; 22(5):466-70. PubMed ID: 10521060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma.
    Aydin D; Sendur MA; Kefeli U; Ustaalioglu BB; Aydin O; Yildirim E; Isik D; Ozcelik M; Surmeli H; Oyman A; Isik S; Sener N; Ercelep O; Odabas H; Aliustaoglu M; Gumus M
    Clin Colorectal Cancer; 2017 Mar; 16(1):78-83. PubMed ID: 27247089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors for cardiotoxicity during fluorouracil and cisplatin combination chemotherapy].
    Kaise M; Yoshino M; Nagai H; Sasaki S; Okura Y; Maruyama Y
    Gan To Kagaku Ryoho; 2014 May; 41(5):601-4. PubMed ID: 24917005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer.
    Groehs RV; Negrao MV; Hajjar LA; Jordão CP; Carvalho BP; Toschi-Dias E; Andrade AC; Hodas FP; Alves MJNN; Sarmento AO; Testa L; Hoff PMG; Negrao CE; Filho RK
    Oncologist; 2020 Dec; 25(12):e1956-e1967. PubMed ID: 32762143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small bowel adenocarcinoma in Lynch syndrome: A case report.
    Sun KK; Liu G; Shen X; Wu X
    Oncol Lett; 2016 Aug; 12(2):1602-1604. PubMed ID: 27446478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history.
    Kelly C; Bhuva N; Harrison M; Buckley A; Saunders M
    Eur J Cancer; 2013 Jul; 49(10):2303-10. PubMed ID: 23583220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small bowel adenocarcinoma.
    Zouhairi ME; Venner A; Charabaty A; Pishvaian MJ
    Curr Treat Options Oncol; 2008 Dec; 9(4-6):388-99. PubMed ID: 19365735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.